Since the launch of the Oncotype DX Colon Cancer Assay, Genomic Health has been collecting colon case studies to use for educational purposes. If you have an interesting case that you’d like to share with us, you can submit the details of the case at www.oncotypedxcsi.com. The site is very easy to use and only takes a few minutes to complete. We truly appreciate you sharing your experiences with the assay as it benefits others to hear firsthand how valuable the test can be in treatment planning for standard risk stage II colon cancer patients.
Standard Risk Stage II Patient
For this patient, how should she be evaluated for treatment and how do you determine her risk of recurrence?
PatientCase
78-year-old female with 4.8-cm tumor
Tumor Type: Adenocarcinoma
Tumor Size: 4.8 cm
T Stage: 3
Histologic Grade: 3
Lymph Node Status: Negative
Number of Lymph Nodes Assessed: 3
Mismatch Repair (MMR Status): MMR-P(IHC)
Lymphovascular Invasion: No
Perforation: No
Obstruction: No
Click here to see this patient’s Recurrence Score:
